(Q24235476)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Antiplatelet agents for preventing and treating pre-eclampsia

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Heparin for pregnant women with acquired or inherited thrombophilias

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Safety and effectiveness of tinzaparin sodium in the management of recurrent pregnancy loss

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Thromboprophylaxis and pregnancy: two randomized controlled pilot trials that used low-molecular-weight heparin.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Use of a computerised maternity information system to improve clinical effectiveness: thromboprophylaxis at caesarean section

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Peripartum prophylaxis of thrombo-embolism

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Hazards of heparin: allergy, heparin-induced thrombocytopenia and osteoporosis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Current concepts of anticoagulant therapy in pregnancy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Lack of anti-factor Xa activity in umbilical cord vein samples after subcutaneous administration of heparin or low molecular mass heparin in pregnant women.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Prevention of thromboembolism with low molecular weight heparin (Fragmin) in obstetrics

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Maternal and fetal sequelae of anticoagulation during pregnancy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Effect of low dose heparin on blood loss at caesarean section.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Maternal mortality in the United States, 1979-1986.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

A pharmacokinetic study of dalteparin (Fragmin) during late pregnancy

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Venous thromboembolic disease in obstetrics and gynaecology: the Scottish experience

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Maternal mortality in Sweden, 1980-1988.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

A prospective study of dextran-induced anaphylactoid reactions in 5745 patients.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Thromboprophylaxis with low molecular weight heparin (dalteparin) in pregnancy

30 May 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001689.PUB2

Low-molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001689.PUB2

Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the Live-Enox study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001689.PUB2

Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001689.PUB2

Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001689.PUB2

Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001689.PUB2

Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial

21 January 2018

2 references

https://api.crossref.org/works/10.1002%2F14651858.CD001689.PUB2

21 January 2018

12 December 2020

The rheological changes after cesarean section: The influence of low molecular weight or unfractionated heparin on the rheological properties of blood.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Thromboprophylaxis following caesarean section--a comparison of the antithrombotic properties of three low molecular weight heparins--dalteparin, enoxaparin and tinzaparin.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

A randomised double-blind placebo controlled trial of low molecular weight heparin as prophylaxis in preventing venous thrombolic events after caesarean section: a pilot study.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

The cumulative incidence of venous thromboembolism during pregnancy and puerperium--an 11 year Danish population-based study of 63,300 pregnancies

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175551

Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial

29 November 2018

1 reference

12 December 2020

Single inherited thrombophilias and adverse pregnancy outcomes

1 reference

12 December 2020

Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications--No

1 reference

12 December 2020

May mothers given warfarin breast-feed their infants?

1 reference

12 December 2020

[Thrombo-embolytic prophylaxis using physiotherapy with and without low doses of heparin in gynecology and obstetrics. Results of a controlled and randomized mult-cancer study]

1 reference

12 December 2020

The risks of antenatal subcutaneous heparin prophylaxis: a controlled trial

1 reference

12 December 2020

Late venous function in the leg after deep venous thrombosis occurring in relation to pregnancy

1 reference

12 December 2020

Prevention of postpartum venous thrombosis with low doses of heparin

1 reference

12 December 2020

1 reference

12 December 2020

Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone

1 reference

12 December 2020

A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin

1 reference

12 December 2020

Randomized trial of aspirin versus aspirin and heparin in pregnant women with the antiphospholipid syndrome

1 reference

12 December 2020

Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production

1 reference

12 December 2020

Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy

1 reference

12 December 2020

Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database

1 reference

12 December 2020

Thromboembolism prophylaxis and cesarean section: a survey of general obstetricians

1 reference

12 December 2020

Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications – Yes

1 reference

12 December 2020

Puerperal thromboprophylaxis: comparison of the anti-Xa activity of enoxaparin and unfractionated heparin

1 reference

12 December 2020

Thrombotic risk during pregnancy: a population study

1 reference

12 December 2020

Management of pregnant women with increased risk of venous thrombosis

1 reference

12 December 2020

Bone density changes in women who receive thromboprophylaxis in pregnancy

1 reference

12 December 2020

The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis

1 reference

12 December 2020

Caesarean Section. Clinical Guideline. National Collaborating Centre for Women's and Children's Health:. Commissioned by the National Institute for Clinical Excellence

1 reference

12 December 2020

The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial

1 reference

12 December 2020

A randomised trial to compare the effect of pre- or postoperative nandroparin on blood loss during elective caesarean section

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001689.PUB2

7 January 2021